In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund
In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund

In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund

Corporate earnings growth is coming back and economic recovery is on track.

Shashikant Singh Article rating: 4.0

As we enter 2022, we have the risk of rate hikes and valuations. However, the Indian market has deepened for all start-ups and the outlook is bright for the longer term, asserts Alok Agarwal, Senior Fund Manager-Equity, PGIM India Mutual Fund.

Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar
Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar

Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar

Company will have to create a nationwide logistic network to execute the orders through the already established dealer and distributor network of IKSL

Shashikant Singh Article rating: 2.3

Company's shares are trading near 52-week high after entering into a strategic and exclusive agreement with IFFCO KISAN Sanchar.

RSS
First89101113151617Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR